Discover 1,665 paid clinical trials in Colorado. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Colorado offers a variety of paid research opportunities, including paid studies for healthy volunteers and trials for those with specific health needs. Research hubs in Denver, Colorado Springs, and Boulder are actively recruiting participants, providing access to innovative treatments and exceptional medical care.
Filter
1
Filter results
Results: 1,665
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
for
Cardiovascular Disease and Lipoprotein(a)
Location: Scarborough ME, Boston MA, Riverhead NY, Hartford CT,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07517263
Phase3, Recruiting
The Vanguard Study: Testing a New Way to Screen for Cancer
for
Bladder Carcinoma, Breast Carcinoma, Colorectal Carcinoma,
Location: Portsmouth VA, Norfolk VA, Bethesda MD, Richmond VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 45 - 70+
Code: NCT06995898
Recruiting
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
for
Sarcoma
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 65 - 70+
Code: NCT07125183
Phase2, Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
for
Extensive Stage Lung Small Cell Carcinoma,
Location: Peabody MA, Boston MA, Burlington MA, Waterford CT,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06769126
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control
for
Chronic Pain, Intractable Pain, Low Back Pain,
Location: The Bronx NY, Trevose PA, Clermont FL, Greenville SC,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT07190807
Recruiting
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Long Island City NY, Danbury CT, Great Neck NY,
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All
Age: 60+
Code: NCT07215390
Phase2, Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
for
Breast Neoplasms
Location: Boston MA, Sherbrooke, Westbury NY, White Plains NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06926868
Phase2, Phase3, Recruiting
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
for
Sepsis, Diagnosis, Emergencies
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 0+
Code: NCT07051668
Recruiting
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Boston MA, Worcester MA, New Haven CT, New York NY,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18+
Code: NCT07032662
Phase2, Recruiting
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
for
Primary Sjögren's Syndrome
Location: Sherbrooke, Mineola NY, Trois-Rivieres, Philadelphia PA,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT06979531
Phase2, Recruiting
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma